Back
iRobot Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
49
IRBT
iRobot
Last Price:
10.24
Seasonality Move:
5.08%
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
66.97
Seasonality Move:
-6.93%
Sell
49
iRobot (IRBT)
is a Sell
Is iRobot a Buy, Sell or Hold?
- The current iRobot [IRBT] share price is $10.92. The Score for IRBT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- IRBT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IRBT Stock Price Chart
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $65.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.
IRBT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 56.39 | Buy |
| Chaikin Money Flow: | -363011 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.21 - 11.15) | Buy |
| Bollinger Bands (100): | (5.25 - 23.31) | Sell |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.32 | Sell |
| Relative Strength Index (14 RSI): | 41.48 | Sell |
| Chaikin Money Flow: | 421582 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.45 - 74.29) | Sell |
| Bollinger Bands (100): | (65.99 - 72.19) | Sell |
IRBT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.59 | Sell |
| 20-day SMA: | 9.7 | Buy |
| 50-day SMA: | 9.03 | Buy |
| 200-day SMA: | 25.3 | Sell |
| 8-day EMA: | 11.06 | Sell |
| 20-day EMA: | 10.21 | Buy |
| 50-day EMA: | 10.6 | Buy |
| 200-day EMA: | 22.46 | Sell |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.78 | Sell |
| 20-day SMA: | 69.19 | Sell |
| 50-day SMA: | 68.67 | Sell |
| 200-day SMA: | 62.8 | Buy |
| 8-day EMA: | 66.34 | Sell |
| 20-day EMA: | 68 | Sell |
| 50-day EMA: | 68.71 | Sell |
| 200-day EMA: | 64.66 | Buy |
iRobot Earnings Growth & IRBT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $0.73 per share, an increase this year of $5.00 per share, and an increase next year of $1.85 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.
iRobot Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||